Amgen appeals over orphan drug biosimilar ban
Amgen has appealed against a German court order issued last Friday, August 4, after having earlier been forced to pull a drug for a rare blood disorder from the German market.
Alexion, a UK-based biologics developer owned by AstraZeneca, asserted orphan drug exclusivity (ODE) rights on its antibody treatment Soliris (eculizumab) against Amgen at the Munich Regional Court earlier this year.
Click here to read the full story.
Latest UPC judges named, more to come
The Unified Patent Court has unveiled the names of 21 newly appointed technically qualified judges.
The UPC published the list of names on its website on Wednesday, August 9. The decision to appoint new TQJs was taken on June 2 by the UPC’s Administrative Committee.
Click here to read the full story.
Interim head of EUIPO Boards of Appeal named
Gordon Humphreys will act as interim president of the EUIPO’s Boards of Appeal from October 1, Managing IP can confirm.
Humphreys, who chairs the First and Third Boards of Appeal, will take on the role once João Negrão, who is the current BoA president, takes over as executive director of the EUIPO.
Click here to read the full story.
Other articles published by Managing IP this week include:
PEP talk: counsel split on whether firms should trumpet partner earnings
Don't be a 'guinea pig' after Medtronic Fed Circuit case: counsel
Weekly take: No harm in senators exploring patent alternatives
AI is changing the way law firms work … here’s how
Five minutes with ... Victoria Randall, IP associate at Finnegan
CJEU more open to EUTM appeals after lengthy lockdown
Syngenta IP head laments ‘missed’ G2/21 opportunity amid EPO quality concerns
Quantum companies: tech complexity creates patent obstacles
Match made in heaven: how firms pick the right merger partners
Elsewhere in IP
Lost in translation
Writer and poet Yilin Wang has settled her copyright case against the British Museum after it admitted it used her translations without permission in an exhibition.
Wilko collapse
UK high street retailer Wilko’s collapse into administration this week has sparked discussion over potential intellectual property implications. Emma Kennaugh-Gallacher, a senior professional support lawyer at IP firm Mewburn Ellis in the UK, said administrators should consider Wilko’s IP assets as early as possible.
Wilko’s brand and range of household products have been protected with a corresponding portfolio of registered trademarks and designs and represent “substantial value,” Kennaugh-Gallacher said.
UKIPO priorities
The UKIPO listed standard essential patents (SEPs) and artificial intelligence among its analysis priorities on Tuesday, August 8. The document identifies the office’s main research objectives for the next 12 to 18 months. The UKIPO also vowed to undertake “ground-breaking research and analysis” to support the development of the UK’s IP framework.
Chinese wall
Dentons has split from its Chinese arm, Dacheng Law Offices, the firm confirmed on Tuesday, August 8. Both entities will operate as separate outfits in the future.
Dentons attributed the decision to the Chinese government’s regulatory mandates on local law firms. Both firms joined forces in 2015 to become the largest law firm globally by headcount, with 6,500 lawyers in around 50 offices.
UPC’s SEP debut
Panasonic has targeted Oppo in the first SEP complaint filed at the Unified Patent Court.
The Japanese tech firm has also filed suits in China, Germany, and the UK, it said in a statement on Wednesday, August 9.
Panasonic has also filed actions against Xiaomi.
The Tetris Effect
The editor-in-chief of tech news website Gizmodo has sued Apple and The Tetris Company in a New York federal court for adapting his book into a film without permission.
Dan Ackerman said he sent his 2016 book “The Tetris Effect” to the company behind the video game, which subsequently hit him with a cease-and-desist notice.
That's it for today, see you again next week.
